Bath & Body Works, Inc. (NYSE:BBWI) Maintains "Outperform" Rating Amid Financial Forecasts

Posted Feb 27 by John Deo

Raymond James reaffirms an "Outperform" rating for Bath & Body Works, Inc. (NYSE:BBWI), with a price target i

Source: Two Blokes Trading

Hafnia Limited (HAFN) Exceeds Earnings Expectations but Misses Revenue Targets

Posted Feb 27 by John Deo

Earnings per share of $0.16 exceeded the estimated $0.13, showcasing strong operational performance. Revenue

Source: Two Blokes Trading

eBay Inc. (NASDAQ:EBAY) Sees Positive Shift with AI Integration and Financial Growth

Posted Feb 27 by John Deo

eBay Inc. (NASDAQ:EBAY) integrates artificial intelligence (AI) tools to enhance platform efficiency and user

Source: Two Blokes Trading

Pearson plc (NYSE: PSO): A Leader in Global Education with Growing Analyst Optimism

Posted Feb 27 by John Deo

The consensus price target for Pearson plc (NYSE: PSO) has increased from $14.5 to $18, indicating analyst co

Source: Two Blokes Trading

Cytek Biosciences, Inc. (NASDAQ:CTKB) Sees Analyst Upgrade Amid Positive Financial Trends

Posted Feb 27 by John Deo

Piper Sandler's analyst David Westenberg upgrades Cytek Biosciences, Inc. (NASDAQ:CTKB) from "Hold" to "Buy"

Source: Two Blokes Trading

Civeo Corporation's Financial Performance Analysis

Posted Feb 27 by John Deo

Civeo Corporation (NYSE:CVEO) reported an EPS of -$1.10, missing the estimated EPS of -$0.27. The com

Source: Two Blokes Trading

Magnite, Inc. (NASDAQ:MGNI) Financial Performance Analysis

Posted Feb 27 by John Deo

Magnite's ROIC of 3.19% is significantly lower than its WACC of 16.40%, indicating inefficiency in generating

Source: Two Blokes Trading

Wingstop Inc. (NASDAQ:WING) Financial Performance and Industry Comparison

Posted Feb 27 by John Deo

Wingstop Inc. (NASDAQ:WING) is a prominent player in the fast-casual restaurant sector, specializing in chicke

Source: Two Blokes Trading

Cullen/Frost Bankers, Inc. (NYSE:CFR) Financial Performance and Peer Comparison

Posted Feb 27 by John Deo

Cullen/Frost Bankers, Inc. (NYSE:CFR) has a Return on Invested Capital (ROIC) of 0.83%, which is lower than i

Source: Two Blokes Trading

Jazz Pharmaceuticals (NASDAQ:JAZZ) Maintains Strong Position with Barclays' Overweight Rating

Posted Feb 27 by John Deo

Barclays maintains an "Overweight" rating for Jazz Pharmaceuticals (NASDAQ:JAZZ), increasing the price target

Source: Two Blokes Trading

Nutanix (NASDAQ:NTNX) Sees Positive Analyst Ratings and Price Target Increase

Posted Feb 27 by John Deo

Barclays has set a new price target for Nutanix (NASDAQ:NTNX) at $94, indicating a potential upside of 38.13%

Source: Two Blokes Trading

Nutanix, Inc. (NASDAQ:NTNX) Maintains Positive Outlook from Barclays

Posted Feb 27 by John Deo

Barclays maintains an "Overweight" rating for Nutanix, Inc. (NASDAQ:NTNX), indicating a positive outlook. The

Source: Two Blokes Trading